BlackRock Fund Advisors - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 29 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2016$2,401,000
-20.4%
600,300
+17.0%
0.00%
-100.0%
Q3 2016$3,017,000
+12.3%
513,014
+4.4%
0.00%0.0%
Q2 2016$2,687,000
+17813.3%
491,196
+15694.1%
0.00%
Q1 2016$15,000
+36.4%
3,110
+24.7%
0.00%
Q4 2015$11,0002,4940.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q4 2015
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 545,000$122,0000.10%
Virtu Financial LLC 236,182$53,0000.00%
Planning Solutions Group LLC 14,293$3,0000.00%
Cutter & CO Brokerage, Inc. 10,000$2,0000.00%
Blume Capital Management, Inc. 2,546$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 17,483$4,0000.00%
Wealthspire Advisors, L.P. 8,235$2,0000.00%
Advisor Group, Inc. 2,100$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 2,250$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders